Web18. avg 2024. · Lexaria is currently focused on the applications of DehydraTECH for the administration of hypertension medication but the technology has multiple applications to … Web10. apr 2024. · Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed a disruptive drug delivery technology with multiple opportunities for success in cannabinoids, oral nicotine and other active pharmaceutical ingredients (“APIs”). Lexaria’s patented DehydraTECH(TM) technology is a formulation and dehydration …
Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive …
Web01. jul 2024. · Lexaria Bioscience Corp is a research-driven company that has developed a patented DehydraTECH™ tech that promotes faster delivery of drugs into the blood $LEXX. 814 Following. 870 Followers. … Web22. mar 2024. · Lexaria Bioscience Corp is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. The Company's lipophilic … daniel martinez zapata uam
Industry Solutions from Lexaria’s DehydraTECHTM Hemp and …
WebThis Intellectual Property License Agreement (this “Agreement”) dated as of May 15, 2024 (the “Effective Date”) is made by and between Lexaria Hemp Corp., a US corporation … Web16. mar 2024. · The Company’s subsidiaries include Lexaria CanPharm ULC, Lexaria CanPharm Holdings Corp., PoViva Corp., Lexaria Hemp Corp., Kelowna Management Services Corp., Lexaria Nicotine LLC and Lexaria Pharmaceutical Corp. Closing Price $2.75: Day's Change. 0.04 (1.48%) Bid--Ask--B/A Size--Day's High 3.05 Day's Low 2.72: … Web21. apr 2024. · Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 25 patents granted and over 50 patents pending worldwide. For more information, please visit www.lexariabioscience.com. CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward … daniel kruglov